Hydrolethalus Syndrome 1 (HYLS1) (Middle Region) Peptide
HYLS1
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits HYLS1
- HYLS1 (Hydrolethalus Syndrome 1 (HYLS1))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-HYLS1 antibody (Catalog #: ARP55449_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- HYLS1 (Hydrolethalus Syndrome 1 (HYLS1))
- Synonymes
- HLS Peptide, 3010015K02Rik Peptide, HYLS1, centriolar and ciliogenesis associated Peptide, HYLS1 Peptide, Hyls1 Peptide
- Sujet
-
This protein is a protein localized to the cytoplasm. Mutations in this protein are associated with hydrolethalus syndrome.
Alias Symbols: FLJ32915, HLS
Protein Interaction Partner: C14orf1,C14orf1
Protein Size: 299 - Poids moléculaire
- 34 kDa
- ID gène
- 219844
- NCBI Accession
- NM_145014, NP_659451
- UniProt
- Q96M11
-
Vous êtes ici:
